LMDXF — LumiraDx Income Statement
0.000.00%
Last trade - 00:00- $1.98m
- $379.27m
- $254.48m
Annual income statement for LumiraDx, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 25.4 | 23.1 | 139 | 421 | 254 |
| Cost of Revenue | |||||
| Gross Profit | 10.8 | 8.82 | 52.9 | 152 | 61 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 121 | 139 | 246 | 575 | 576 |
| Operating Profit | -95.2 | -116 | -106 | -153 | -321 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -127 | -143 | -251 | -97.9 | -443 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -115 | -133 | -241 | -101 | -448 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -115 | -133 | -241 | -101 | -448 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -115 | -133 | -241 | -101 | -448 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.424 | -0.507 | -0.909 | -0.443 | -1.36 |
| Dividends per Share |